We are live on ! Find out more
CELUW

Celularity Inc

Delisted

CELUW was delisted on the 17th of July, 2026.

22 hedge funds and large institutions have $4.44M invested in Celularity Inc in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

5.26% more ownership

Funds ownership: 0%5.26% (+5.3%)

5% more funds holding

Funds holding: 2122 (+1)

55% less capital invested

Capital invested by funds: $9.84M → $4.44M (-$5.4M)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
8
Closed
5
Calls
$578K
Puts
Net Calls
+$578K
Net Calls Change
-$1.52M

CELUW Hedge Fund Activity: Q2 2022 in Review

22 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q2 2022, worth a combined $4.44M — down 55% from $9.84M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CELUW positions and 5 closed out — a net gain of 1 holder — while 3 added to existing stakes and 8 trimmed.

The largest buyer was RPO LLC, opening a new position worth an estimated $348K. The largest seller was Linden Advisors, cutting an estimated $233K.

  • 22 institutional investors held Celularity Inc (CELUW) as of Q2 2022, up from 21 in Q1 2022.
  • Funds reported $4.44M of Celularity Inc stock for Q2 2022, down 55% quarter-over-quarter.
  • 6 funds opened new Celularity Inc positions in Q2 2022 and 5 closed out, a net change of +1 holder.
  • The largest Celularity Inc buyer in Q2 2022 was RPO LLC, an estimated $348K added.
  • The largest Celularity Inc seller in Q2 2022 was Linden Advisors, an estimated $233K sold.

Based on aggregated 13F filings for Q2 2022.